The R&D Business Capabilities Lead is responsible for enabling R&D planning, operations, and decision making by equipping asset development teams, functional staff, and senior leaders with industry-
leading project, portfolio, and clinical study management tools, methodologies, analyses, business process design, performance measurement, and consultative support.
The R&D Business Capabilities Lead will manage our project and portfolio management system (a core component of our R&D business capabilities), guide the R&D Business Capabilities Manager and Specialists, and be responsible for senior stakeholder engagement.
The R&D Business Capabilities Team is part of the R&D Strategy and Planning (RDSP) division, which is accountable for R&D business strategy & operations, operating model transformation, drug development project & portfolio management (PPM), governance management, and learning.
The R&D Business Capabilities Lead reports to the RDSP Head of R&D Business Capabilities.
The R&D Business Capability Lead will work with the Head of R&D Business Capabilities to develop and execute the business strategy and operations of our R&D business capabilities.
As such, it is critical that they are able to effectively and efficiently engage and manage senior stakeholders, working with leaders throughout the business, Information Technology, Business Insights and Analytics, and R&D Finance in pursuit of clear and accurate planning, process optimization, and capability evolution.
In partnership with enterprise teams and external partners, the R&D Business Capability Lead will :
functional drug development project managementCapacity management, resource management, and resource forecastingBudgeting, cost planning, and cost forecastingProject, operational, and portfolio scenario planningReporting and dashboardingOperational data quality and metrics
The successful candidate must be able to drive the successful delivery of project objectives by ensuring effective stakeholder management, alignment and business engagement, and provide guidance to staff and business leaders to improve project execution and remove barriers to successful execution.
The candidate will enable planning capabilities and leverage expertise within the organization to drive business objectives, resolve business issues, and optimize opportunities.
As such, a critical aspect of this role is the ability to work seamlessly across the BMS enterprise (both within and outside R&D), coordinating the input of other stakeholders while delivering creative and pragmatic business solutions.
Bristol-Myers Squibb R&D is a science-driven, passionate organization determined to discover, develop and deliver medicines that have the potential to transform the lives of patients and establish new standards of care in areas of high unmet need.
Patients’ needs and scientific discovery are our driving force.
We have a history of scientific excellence. We dramatically changed outcomes in HIV; we helped discover a cure for HCV; and we developed a novel medicine with proven benefit for atrial fibrillation.
We also pioneered targeting the immune system in cancer research, breaking new ground in the science of immuno-oncology.
Today, we are transforming the way certain cancers are treated and focusing our research efforts on areas of high unmet need in cardiovascular disease, immunoscience and fibrosis.
Our goal is to leave an enduring positive impact on society by making a meaningful difference in the lives of even more patients.
Our people are our greatest asset. Our R&D organization is made up of industry-leading researchers and drug developers who have a passion for science, a curiosity for discovery and a commitment to translating these advances into medicines that make a difference for patients.
Our teams are part of a unique global ecosystem that is set up to be agile, interactive and conducive to translating a nascent idea into a powerful treatment.
We follow the science. Our pipeline of promising molecules and medicines is deliberately built through a multi-disciplinary, collaborative approach.
We are deepening our understanding of disease biology and uncovering biomarker insights to help predict how patients will respond to treatment with the ultimate goal of making precision medicine a reality for more patients.
We believe partnership and collaboration are essential. Academic research centers, laboratories, clinicians, clinical trials organizations, government, advocates and industry all of these organizations contribute to a vibrant healthcare ecosystem that is critical to continued scientific advancement.
From the global research networks we’ve created to our creative approach to business development, we complement internal innovation with external innovation identifying new scientific hypotheses to better understand how to translate research findings into improved patient outcomes.
We believe digital health and data connectivity is transforming our industry. Over the past few years, there has been an explosion of available electronic medical records, genomics and claims data.
This, combined with our own data, biomedical and health informatics partnerships, and new analytical tools, is changing how we interact with payers, suppliers and patients.
By leveraging the collective power of data & analytics, we are accelerating the pipeline, enhancing the speed of clinical trials, demonstrating the value of our medicines and helping to inform clinical decisions.
We are constantly anticipating what’s coming next, navigating and discovering new technologies, enabling our understanding of new ways to use them and applying them to advance drug discovery, development and delivery to patients as quickly as possible.
Our mission is clear : to discover, develop and deliver innovative medicines to patients with serious diseases.